Oxcarbazepine-Induced Central Hypothyroidism: Recheck Thyroid Function and Monitor Clinically
The next step is to recheck free T4 and TSH in 4-8 weeks while continuing oxcarbazepine, and monitor for hypothyroid symptoms. If free T4 remains low with normal/low TSH (confirming central hypothyroidism pattern), consider levothyroxine replacement therapy targeting free T4 in the upper half of the reference range.
Understanding the Clinical Picture
This patient demonstrates a classic pattern of oxcarbazepine-induced central hypothyroidism—low free T4 (0.81 ng/dL, just below 0.82) with inappropriately normal TSH (1.640 uIU/mL). This is a well-documented side effect where oxcarbazepine interferes with hypothalamic-pituitary regulation of thyroid function rather than causing primary thyroid gland dysfunction 1, 2, 3.
The elevated SHBG (134.0 nmol/L) and low DHEA-S (81.6 ug/dL) are also consistent with oxcarbazepine effects on hepatic protein synthesis and hormone metabolism 4.
Why This Matters
Central hypothyroidism differs fundamentally from primary hypothyroidism:
- TSH remains normal or low despite inadequate thyroid hormone, because the pituitary fails to respond appropriately 1
- TSH cannot be used as a monitoring parameter—only free T4 levels guide diagnosis and treatment 5
- This pattern occurs in 24-67% of patients on oxcarbazepine, particularly within the first 2 years of treatment 2, 6
Immediate Management Algorithm
Step 1: Confirm the Diagnosis (4-8 weeks)
- Repeat free T4 and TSH 5
- If free T4 remains low with normal/low TSH, central hypothyroidism is confirmed
- Check morning cortisol to exclude adrenal insufficiency (which can present similarly) 5
Step 2: Assess Clinical Impact
Evaluate for hypothyroid symptoms:
- Fatigue, weight gain, cold intolerance
- Cognitive slowing, depression
- Menstrual irregularities (relevant given the reproductive hormone workup)
- Growth concerns if pediatric patient
Three of four patients in a case series experienced symptomatic hypothyroidism requiring treatment 1.
Step 3: Treatment Decision
If symptomatic OR free T4 persistently <0.80 ng/dL:
- Initiate levothyroxine replacement
- Target free T4 in the upper half of the reference range (approximately 1.3-1.77 ng/dL for this lab's range) 5
- Starting dose: 50-75 mcg daily for adults
- Recheck free T4 (not TSH) in 4-8 weeks after dose adjustments 5
If asymptomatic with borderline low free T4:
- Monitor free T4 every 3-6 months
- Educate patient about hypothyroid symptoms
- Consider treatment if free T4 declines further
Critical Pitfalls to Avoid
Do not rely on TSH alone for monitoring—this is the most common error. TSH will remain normal despite inadequate thyroid hormone in central hypothyroidism 1, 2, 7.
Do not assume this is subclinical hypothyroidism—the normal TSH with low free T4 indicates central, not primary, thyroid dysfunction. The guidelines for subclinical hypothyroidism (elevated TSH with normal free T4) do not apply here 8, 5.
Do not discontinue oxcarbazepine precipitously unless seizure control allows—sudden discontinuation risks status epilepticus 9. Thyroid replacement is safer than changing seizure medication if oxcarbazepine is effective.
Alternative: Discontinuing Oxcarbazepine
If seizure control permits switching antiepileptic drugs, thyroid function normalizes within weeks to months after oxcarbazepine discontinuation 1, 6. Lamotrigine has the least disruptive effect on thyroid hormones among antiepileptic drugs 10.
However, medication changes should be coordinated with the prescribing neurologist/psychiatrist, weighing seizure control against endocrine effects.
Addressing the Other Abnormalities
The elevated SHBG is a direct hepatic effect of oxcarbazepine 4 and explains the normal free testosterone despite potentially low-normal total testosterone. This typically requires no intervention unless symptomatic.
The low DHEA-S may also relate to oxcarbazepine effects on adrenal androgen production 4. If persistent, consider adrenal function testing, though isolated low DHEA-S without other adrenal insufficiency signs is often benign.
Long-Term Monitoring
For patients continuing oxcarbazepine:
- Check free T4 (not TSH) every 6-12 months 2
- Most pronounced thyroid effects occur in the first 2 years 2, 6
- Effects are reversible with drug discontinuation 6
The FDA label for oxcarbazepine notes that "laboratory data from clinical trials suggest that oxcarbazepine use was associated with decreases in T4, without changes in T3 or TSH" 9, confirming this is a recognized drug effect requiring monitoring.